These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 34059421)

  • 1. Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease.
    Marques CR; Pereira-Sousa J; Teixeira FG; Sousa RA; Teixeira-Castro A; Salgado AJ
    Cytotherapy; 2021 Oct; 23(10):894-901. PubMed ID: 34059421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretome of bone marrow mesenchymal stromal cells cultured in a dynamic system induces neuroprotection and modulates microglial responsiveness in an α-synuclein overexpression rat model.
    Marques CR; Campos J; Sampaio-Marques B; Antunes FF; Dos Santos Cunha RM; Silva D; Barata-Antunes S; Lima R; Fernandes-Platzgummer A; da Silva CL; Sousa RA; Salgado AJ
    Cytotherapy; 2024 Jul; 26(7):700-713. PubMed ID: 38483360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
    Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
    PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans.
    Chen KS; Menezes K; Rodgers JB; O'Hara DM; Tran N; Fujisawa K; Ishikura S; Khodaei S; Chau H; Cranston A; Kapadia M; Pawar G; Ping S; Krizus A; Lacoste A; Spangler S; Visanji NP; Marras C; Majbour NK; El-Agnaf OMA; Lozano AM; Culotti J; Suo S; Ryu WS; Kalia SK; Kalia LV
    Mol Neurodegener; 2021 Nov; 16(1):77. PubMed ID: 34772429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease.
    Harrington AJ; Yacoubian TA; Slone SR; Caldwell KA; Caldwell GA
    J Neurosci; 2012 Feb; 32(6):2142-53. PubMed ID: 22323726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diterpene glycosides from Holothuria scabra exert the α-synuclein degradation and neuroprotection against α-synuclein-Mediated neurodegeneration in C. elegans model.
    Chalorak P; Sornkaew N; Manohong P; Niamnont N; Malaiwong N; Limboonreung T; Sobhon P; Aschner M; Meemon K
    J Ethnopharmacol; 2021 Oct; 279():114347. PubMed ID: 34147616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-γ-(L-glutamyl)-L-selenomethionine shows neuroprotective effects against Parkinson's disease associated with SKN-1/Nrf2 and TRXR-1 in Caenorhabditis elegans.
    Chang CH; Wei CC; Ho CT; Liao VH
    Phytomedicine; 2021 Nov; 92():153733. PubMed ID: 34537465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling.
    Kautu BB; Carrasquilla A; Hicks ML; Caldwell KA; Caldwell GA
    Neurosci Lett; 2013 Apr; 541():116-9. PubMed ID: 23485787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-α-synuclein Toxicity and Anti-neurodegenerative Role of Chrysin in Transgenic
    Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
    ACS Chem Neurosci; 2022 Feb; 13(4):442-453. PubMed ID: 35118868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity.
    Kim H; Calatayud C; Guha S; Fernández-Carasa I; Berkowitz L; Carballo-Carbajal I; Ezquerra M; Fernández-Santiago R; Kapahi P; Raya Á; Miranda-Vizuete A; Lizcano JM; Vila M; Caldwell KA; Caldwell GA; Consiglio A; Dalfo E
    Mol Neurobiol; 2018 Sep; 55(9):7533-7552. PubMed ID: 29429047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections of
    Kitisin T; Muangkaew W; Sukphopetch P
    Front Cell Infect Microbiol; 2022; 12():1039336. PubMed ID: 36389163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Holothuria scabra extracts exhibit anti-Parkinson potential in C. elegans: A model for anti-Parkinson testing.
    Chalorak P; Jattujan P; Nobsathian S; Poomtong T; Sobhon P; Meemon K
    Nutr Neurosci; 2018 Jul; 21(6):427-438. PubMed ID: 28276260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
    Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA
    J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of metformin on dopaminergic neurodegeneration and α-synuclein aggregation in C. elegans model of Parkinson's disease.
    Saewanee N; Praputpittaya T; Malaiwong N; Chalorak P; Meemon K
    Neurosci Res; 2021 Jan; 162():13-21. PubMed ID: 31881233
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans.
    Gaeta AL; Nourse JB; Willicott K; McKay LE; Keogh CM; Peter K; Russell SN; Hamamichi S; Berkowitz LA; Caldwell KA; Caldwell GA
    PLoS Genet; 2022 Aug; 18(8):e1010115. PubMed ID: 35984862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson's Disease.
    Tsai CW; Tsai RT; Liu SP; Chen CS; Tsai MC; Chien SH; Hung HS; Lin SZ; Shyu WC; Fu RH
    Cell Transplant; 2017 Dec; 26(12):1903-1918. PubMed ID: 29390878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and α-synuclein accumulation in C. elegans models of Parkinson's disease.
    Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
    Neurotoxicology; 2022 Dec; 93():128-139. PubMed ID: 36108815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rose essential oil diminishes dopaminergic neuron degenerations and reduces α-synuclein aggregation in Caenorhabditis elegans models of Parkinson's disease.
    Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
    Phytother Res; 2023 Jul; 37(7):2877-2893. PubMed ID: 36920348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCEH-1 modulates cholesterol metabolism and protects against α-synuclein toxicity in a C. elegans model of Parkinson's disease.
    Zhang S; Glukhova SA; Caldwell KA; Caldwell GA
    Hum Mol Genet; 2017 Oct; 26(19):3823-3836. PubMed ID: 28934392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.